关于大麻素在耐药性症中的最新情况
Akanksha Singh1, Priyanka Madaan2, Dipika Bansal1
1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab, India.
Indian journal of pediatrics
|November 25, 2024
概括
大麻 (CBD) 显示出治疗儿童耐药性的前景,减少发作和改善生活质量. 在印度等国家,成本和获取是广泛采用的关键考虑因素.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
背景情况:
- 耐药性 (DRE) 在儿科患者群体中存在重大挑战.
- 大麻 (CBD) 正在成为特定儿科综合征的潜在治疗剂.
- 美国,欧洲和印度已经对DRE中的CBD获得了监管批准.
研究的目的:
- 审查CBD的药理性质和作用机制.
- 评估CBD在儿科的临床证据,如伦诺克斯·加斯托综合征 (LGS),德拉维特综合征 (DS) 和结核性硬化综合体 (TSC).
- 检查CBD在印度的监管地位和成本效益.
主要方法:
- 对CBD疗效和安全的临床试验和观察性研究的审查.
- 对药理学数据的分析和建议的作用机制.
- 评估印度的监管环境和经济因素.
主要成果:
- CBD在降低发作频率和提高DRE儿童的生活质量方面表现出潜力.
- 常见的不良事件通常是轻微的,包括昏昏欲睡和胃肠道问题.
- 对于CBD的成本构成一个重要的障碍,特别是在低收入和中等收入国家.
结论:
- 对于儿科DRE来说,CBD是一种有前途的治疗方法,具有既定的疗效和普遍有利的安全性.
- 需要进一步的研究和政策制定,以应对成本和可访问性挑战,特别是在印度.
- 将CBD整合到临床实践中需要仔细考虑其药理学,临床和经济方面.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251
Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283
Antiepileptic Drugs: Sodium Channel Blockers
426
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
426
Antiepileptic Drugs: Calcium Channel Blockers
320
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
320


